… Epidermal growth factor receptor (EGFR) is an Mr 170,000 … epidermal growth factor (EGF)
or transforming growth factor-a to … Epidermal growth factor receptor and the structurally related …

… , survival analysis was restricted to the group of diffuse astrocytomas (51 cases). There
were 30 men and 21 women with a mean age of 55.4 years (range 31-79 years). The follow-up …

… Purpose: Somatic mutations of the epidermal growth factor receptor (EGFR) gene are
associated with an increased response to gefitinib in patients with non–small cell lung cancer. We …

… analysis [5, 6]. Moreover, one should be cautious not to generalise the results of the analysis
of prognostic factors … analysis, the prognostic factors associated with the survival of patients …

… growth factor (VEGF), PFS6 for recurrent GBM was 30% and for AG, 56% [4]. A second phase
II study randomized 167 recurrent GBM patients to treatment with bevacizumab alone or in …

… growth initiated by interaction between EGFR and its ligands, epidermal growth factor (EGF)/transforming
growth factor alpha (… EGFR overexpression and altered survival in patients with …

… growth factor receptor (EGFR) overexpression(as assessed by immunohistochemistry), p53
immunopositivity, or p53 mutation with survival … with worse survival was identified in the p53-…

… A correlative study was performed to address the impact of epidermal growth factor receptor
(EGFR) overexpression on survival and pattern of failure in patients with advanced head …

… survival analysis, we defined overall survival (starting from time of diagnosis) and relapse-free
survival … Univariate survival analysis included Kaplan-Meier curves and log-rank tests. In …

… is to discuss the mechanism by which factor deprivation can lead to apoptosis and to describe
situations in which peptide growth factors act as survival factors. Growth factor deprivation …